Literature DB >> 22319742

Simultaneous forequarter amputation and radical mastectomy for metastatic breast carcinoma in a male patient: a case report.

Mehmet Ayvaz1, Caglar Yilgor, Musa Ugur Mermerkaya, Ali Konan, Erhan Sonmez, Rifat Emre Acaroglu.   

Abstract

Although the majority of forequarter amputations are performed for high-grade bone and soft tissue sarcomas or extensive osteomyelitis of the upper extremity, this radical operation may also be indicated for the curative treatment of recurrent breast cancer and for the palliation of locally advanced breast cancer. We report a male patient with metastatic breast adenocarcinoma who underwent simultaneous mastectomy and forequarter amputation for the management of both his primary and metastatic disease.

Entities:  

Keywords:  Amputation; Breast neoplasms; Male; Radical mastectomy

Year:  2011        PMID: 22319742      PMCID: PMC3267069          DOI: 10.4174/jkss.2011.81.Suppl1.S6

Source DB:  PubMed          Journal:  J Korean Surg Soc        ISSN: 1226-0053


  10 in total

1.  UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

Authors:  R Peto; J Boreham; M Clarke; C Davies; V Beral
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

2.  Interscapulothoracic amputation.

Authors:  M B Yoak; W M Cocke; J P Carey
Journal:  W V Med J       Date:  2001 May-Jun

3.  Is forequarter amputation justified for palliation of intractable cancer symptoms?

Authors:  O Merimsky; Y Kollender; M Inbar; D Lev-Chelouche; M Gutman; J Issakov; D Mazeh; S Shabat; J Bickels; I Meller
Journal:  Oncology       Date:  2001       Impact factor: 2.935

Review 4.  Palliative forequarter amputation for metastatic carcinoma to the shoulder girdle region: indications, preoperative evaluation, surgical technique, and results.

Authors:  J C Wittig; J Bickels; Y Kollender; K L Kellar-Graney; I Meller; M M Malawer
Journal:  J Surg Oncol       Date:  2001-06       Impact factor: 3.454

5.  Major amputations done with palliative intent in the treatment of local bony complications associated with advanced cancer.

Authors:  M M Malawer; R G Buch; W E Thompson; P H Sugarbaker
Journal:  J Surg Oncol       Date:  1991-06       Impact factor: 3.454

Review 6.  Forequarter amputation for recurrent breast cancer: a case report and review of the literature.

Authors:  Michael D Goodman; Benjamin McIntyre; Elizabeth A Shaughnessy; Andrew M Lowy; Syed A Ahmad
Journal:  J Surg Oncol       Date:  2005-11-01       Impact factor: 3.454

7.  Breast carcinoma in men: a population-based study.

Authors:  Sharon H Giordano; Deborah S Cohen; Aman U Buzdar; George Perkins; Gabriel N Hortobagyi
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

8.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

9.  Surgical treatment for chest wall invasion due to the local recurrence of breast cancer.

Authors:  Takeshi Hanagiri; Tadahiro Nozoe; Takashi Yoshimatsu; Makiko Mizukami; Yoshinobu Ichiki; Masakazu Sugaya; Manabu Yasuda; Mitsuhiro Takenoyama; Kenji Sugio; Hiroshi Yasuda; Kosei Yasumoto
Journal:  Breast Cancer       Date:  2008-03-06       Impact factor: 4.239

10.  Forequarter amputation for malignancy.

Authors:  J Rickelt; H Hoekstra; F van Coevorden; R de Vreeze; C Verhoef; A N van Geel
Journal:  Br J Surg       Date:  2009-07       Impact factor: 6.939

  10 in total
  2 in total

Review 1.  Curative use of forequarter amputation for recurrent breast cancer over an axillary area: a case report and literature review.

Authors:  Chun-Hao Tsai; Huey-En Tzeng; Wei-Kae Juang; Pei-Guo Chu; Patricia Fann; Yi-Chin Fong; Horng-Chaung Hsu; Yun Yen
Journal:  World J Surg Oncol       Date:  2014-11-18       Impact factor: 2.754

2.  Forequarter amputation for recurrent breast cancer.

Authors:  Krishna N Pundi; Yazan N AlJamal; Raaj K Ruparel; David R Farley
Journal:  Int J Surg Case Rep       Date:  2015-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.